EGFR TKI

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

EGFR TKI

Aug 26, 2024, 21:24 | Blog

Tanja Obradovic: Can we expect new EGFR TKI to surpass osimertinib in primary tumor and intracranial progression of NSCLC

Tanja Obradovic posted on LinkedIn: “Can we expect new EGFR TKI that can significantly surpass…

Aug 6, 2024, 01:06 | Insight

Metastatic lung adenocarcinoma with EGFR and TP53 co-mutations shows mixed intra-patient tumor responses

Yüksel Ürün shared on X: "Metastatic lung adenocarcinoma with Epidermal Growth Factor Receptor (EGFR) and…

May 29, 2024, 09:22 | Blog

Eric K. Singhi: Isn’t it about time we stopped saying that "patients failed treatment"

Eric K. Singhi reshared his previous post on X and added: ; "But…

Feb 5, 2024, 11:27 | Insight

Stephen V Liu: The optimal strategy for unresectable stage III NSCLC after chemoradiation in EGFR mutant NSCLC

Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…

All: 4 Posts: 1 - 100

Kamala Harris vs Donald Trump on Cancer: From Cancer Moonshot to Right to Act, Funding, Research and Future

New €4.9m Beaumont RCSI Cancer Centre and Irish Cancer Society Partnership to Transform Lung Cancer Care in Ireland

Biden Cancer Moonshot Initiative Awards Over $6 Million to 11 Early-Career Researchers for Innovative Cancer Research

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Special Coverage

ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023